Talent Arena Official Program

Beyond Agentic AI: Designing the Future of Healthcare with Women in STEM 
Plug-in Talks ​

At AstraZeneca, science, data and technology drive AI-enabled healthcare. We’re advancing from generative AI (faster thinking/learning) to agentic AI (acting across complex systems) across discovery, development, evidence and patient care. The Hub blends scientific rigor, digital expertise and responsible AI, builds the future workforce,especially women in STEM, and offers frontier opportunities, non-linear careers and purpose-led impact.​

Moderador: Cesar Velasco, MD, PhD. Enterprise Innovation Madrid & Barcelona Director at AstraZeneca​ Participantes: Cecilia Girón, Director of Data Science at Evinova; Elena Millán, Director, RDU IT – Product Management, Knowledge Management, and AI Content Supply Chain at Alexion, Marta Tolos, Executive Director, Enterprise AI Platforms & Services at AstraZeneca

11:30h - 12:30​h

Add to calendar

Talent Arena Official Program

The Future of Enterprise AI Governance
Visionary Stage ​
Keynote

AI is now democratized, reshaping every role and organization. As it becomes embedded in work, how do we keep it trustworthy, compliant, and safe? Enterprise AI Governance is critical, yet most organizations are just beginning. Oliver Patel, who leads AI governance at AstraZeneca and authored Fundamentals of AI Governance, shares how regulations are evolving, why AI literacy is essential, and how agentic AI changes the game. ​

Speaker: Oliver Patel, Head of Enterprise Artificial Intelligence Governance at AstraZeneca ​

12:00h - 12:30​h

Add to calendar

AstraZeneca Sky Stage

Opening Keynote: The Power of Artificial Intelligence in a Global Health Hub
Hall 8.0 – 4YFN & Partner Theatres
Keynote

Opening keynote setting the strategic context for the day, outlining AstraZeneca’s global innovation vision and the role of digital technologies, AI and data-driven science in reshaping healthcare, R&D and patient outcomes.​

David Dellamonica, VP Head of AI to Transform Care

10:00h - 10:15h

Add to calendar

Engineering Rare Disease Care: Virtual Human Twins and Augmented Reality
Hall 8.0 – 4YFN & Partner Theatres
Roundtable

Expert roundtable exploring how digital twin technologies are being applied in rare diseases to accelerate clinical development, simulate disease progression, optimise trial design and improve decision‑making in high–unmet‑need areas.

Moderator:  Ricardo Damas. VP and General Manager Alexion Iberia Participants: Antonio Quesada, Digital Lead Alexion Iberia; Diego Argüello, Director Clinical Development Scientist Alexion Pharmaceuticals

10:15h - 10:45h

Add to calendar
 

From Algorithms to Impact: How Artificial Intelligence Is Transforming Care at Scale
Hall 8.0 – 4YFN & Partner Theatres
Roundtable

This session examines how AI solutions move beyond pilots to deliver measurable impact at scale.

Moderator: Christophe Dufour. Global Head of Digital Precision Healthcare at AstraZeneca​ Participants: Martina Furegato. Principal / Senior Manager – RWE at Oracle Life Sciences​; Meriem Sefta. Chief Diagnostic Officer at Owkin Dx ; Raul Herance. MD, Head of the Medical Molecular Imaging Research Group at Vall d’Hebron Research Institute"

10:45h - 11:15h

Add to calendar
 

AstraZeneca Global Hub in Barcelona: How Tech Is Transforming Care
Hall 8.0 – 4YFN & Partner Theatres
Roundtable

Discussion on how digital tools, data platforms, and emerging technologies are reshaping care pathways and enabling more proactive, efficient, and patient‑centred healthcare models.

Moderator: Marta Tolos. Executive Director Enterprise AI Platforms at AstraZeneca​ Panelists: Mario Sänger. Associate Principal AI Engineer at AstraZeneca; Madalina Ciortan. Director AI OpsIT at AstraZeneca; Michael Crandford. Director Commercial IT Data & AI Capabilities at AstraZeneca; Panagiotis Sereleas. Director RDU IT Data Science at AstraZeneca; Albert Maristany. Product Lead BIKG R&D IT at AstraZeneca

11:15h - 11:45h

Add to calendar
 

Smarter Trials for a Healthier Future
Hall 8.0 – 4YFN & Partner Theatres
Keynote

Forward‑looking roundtable on the evolution of clinical trials, transforming how evidence is generated and accelerating access to innovation.

Moderator: César Velasco. MD, PhD. Enterprise Innovation Director Madrid & Barcelona​ Panelists: Mercedes Luz. PhD. Sr. Director, Cluster Head Biopharmaceuticals Site Management & Monitoring; Emiliano Calvo, MD, PhD. Director Europa START Madrid -CIOCC Unit, Early Phase clinical trials​; Antonio L. Andreu, MD, PhD. Scientific Director EATRIS

12:00h - 12:30h

Add to calendar
 

The Last Mile of Artificial Intelligence: From Global to Local
Hall 8.0 – 4YFN & Partner Theatres
Roundtable

A practical discussion on the challenges of deploying global AI strategies within our bio‑region, drawing on the learnings and capabilities of the A.Catalyst Network, a global network of innovation hubs.

Moderator: Madeleine Thun, Senior Director A.Catalyst Network AstraZeneca​ Panelists: Miguel Lancha, Enterprise Innovation Lead & Global Transform Care Director; Gwen Jacquand, Digital, Health & Innovation Director; David Coelingh Bennink, Head of Policy

12:30h - 13:00h

Add to calendar
 

Opening: Leading the Transformation of the Healthcare System through AstraZeneca’s Spanish Healthcare Innovation Hub
Hall 8.0 – 4YFN & Partner Theatres
Keynote

Bienvenida institucional por parte de AstraZeneca España, destacando el compromiso de la compañía con la transformación del sistema sanitario en España.

Speaker: Laura Colón. President of AstraZeneca Spain and Site Leader of the AstraZeneca Global Hub in Barcelona

14:30h - 14:40h

Restricted access by invitation only. Acceso restringido solo con invitación

Add to calendar
 

Human in the Loop: The Next Frontier of Health Innovation
Hall 8.0 – 4YFN & Partner Theatres
Keynote

Sesión centrada en el papel fundamental de los profesionales sanitarios, los pacientes y los actores del ecosistema sanitario en la innovación impulsada por la inteligencia artificial.

Moderador: Dra. Katherin Martínez-Barroso, MBA. Enterprise Innovation Manager en AstraZeneca Participantes: Dr. Joaquín Rodríguez. PhD, MBA.. Especialista en Aparato Digestivo. Jefe de servicio digestivo Quirón Salud CLM. Divulgador de IA Ignacio Sarasúa, PhD, MBA. Solution Architect at NVIDIA, Digital Health

14:40h - 15:00h

Restricted access by invitation only. Acceso restringido solo con invitación

Add to calendar
 

AI‑Powered Oncology: From Promise to Clinical Impact Innovation
Hall 8.0 – 4YFN & Partner Theatres
Panel

Tres estudios clínicos en distintas fases de desarrollo muestran cómo la inteligencia artificial puede aplicarse al diagnóstico precoz, la detección de efectos adversos y el análisis de imagen en oncología. Un debate honesto sobre evidencia, retos y el verdadero impacto de la IA en la práctica clínica.

Moderador: Dra. Ana Peiró. Head of Oncology AstraZeneca​ Participantes:  Dra. Regina García Delgado,  Hematóloga en Hospital Universitario Virgen de la Victoria Málaga & Investigadora responsable del Grupo BE21: Hematología e Inmunoterapia, IBIMA Plataforma BIONAND. Dr. Alfonso Cortés Salgado, Oncólogo Médico (Sección de tumores de mama y ginecológicos) en Hospital Universitario Ramón y Cajal Madrid; Dr. Luis Gorospe-Sarasúa, Radiólogo torácico en Hospital Universitario Ramón y Cajal Madrid.

15:00h - 15:30h

Restricted access by invitation only. Acceso restringido solo con invitación

Add to calendar
 

From Data to Clinical Action in Cardiovascular, Renal, and Metabolic CareInnovation
Hall 8.0 – 4YFN & Partner Theatres
Panel

Presentación de distintos casos de herramientas de apoyo a la toma de decisiones clínicas y cómo mejoran los circuitos asistenciales para pacientes con patologías CVRM​.

Moderador: Ilmo. Sr. D. Bernardo Valdivieso. Secretario autonómico de Planificación, Información y Transformación Digital en la Conselleria de Sanidad de la Generalitat Valènciana. Participantes: Dr. Enrique Rodríguez, Jefe de Servicio del Laboratorio de Bioquímica Clínica y Patología Molecular del Hospital Clínico de Valencia ;Dr.  Emilio Flores, Jefe de Servicio del Laboratorio Clínico del Hospital del Hospital de San Juan de Alicante; Dra. Maribel Troya Saborido, Servicio Nefrologia, Hospital Universitari Germans Trias i Pujol, Badalona

15:30h - 16:00h

Restricted access by invitation only. Acceso restringido solo con invitación

Add to calendar
 

Detecting Signals, Transforming Decisions in the Clinical Setting - Artificial Intelligence and Amyloidosis Innovation
Hall 8.0 – 4YFN & Partner Theatres
Panel

Cómo las herramientas basadas en inteligencia artificial están permitiendo una detección más temprana de la amiloidosis por transtiretina (ATTR), mejorando los circuitos diagnósticos y apoyando a los profesionales sanitarios en procesos de toma de decisiones complejas.

Moderador: Miguel Lancha Luquero. Entreprise Innovation Lead​ Participantes: Dr. Manuel Marina Breysse. CEO, cardiólogo y cofundador de IDOVEN. ​ Dra. Esther González López. Médico adjunto e investigadora clínica. Unidad de Cardiopatías Familiares. Hospital Universitario Puerta de Hierro; Christine Gouillard. Responsable de Alianzas y enlace médico en Us2.ai.; Dr. Albert Teis Soley. Adjunto del Servicio de Cardiología. Departamento de Imagen Cardiovascular. Institut del Cor. Hospital Germans Trias i Pujol.

16:30h - 17:00h

Restricted access by invitation only. Acceso restringido solo con invitación

Add to calendar
 

From Reactive to Proactive Care: AI‑Driven Early Intervention for Chronic Patients Innovation
Hall 8.0 – 4YFN & Partner Theatres
Panel

Casos reales sobre cómo la integración de inteligencia artificial y datos clínicos está permitiendo una detección más temprana del riesgo en enfermedades crónicas, con el lupus, asma grave y EPOC​

Moderador: Jorge del Estal, Unidad de Farmacia Ambulatoria Hospital Universitario Parc Tauli ​ Participantes: Dr. Javier Bachiller, Jefe de Sección Reumatología en Hospital Universitario Ramón y Cajal; Isaac Cano. CEO HealthCircuit; Dra. Ebymar Arismendi, Coordinadora Unidad Asma Grave en Hospital Clinic; Dr. Carlos Egea, Jefe de Servicio Neumología Hospital Universitario Araba; Dr. José Manuel Calleja, Médico especialista en Medicina de Familia y Comunitaria en Osakidetza

17:00h - 17:40h

Restricted access by invitation only. Acceso restringido solo con invitación

Add to calendar
 

Physicians and AI: Collaborating for Better Patient Care. From Reactive to Proactive Care: AI‑Driven Early Intervention for Chronic Patients Innovation
Hall 8.0 – 4YFN & Partner Theatres
Roundtable

Esta ponencia explora cómo médicos y tecnología pueden colaborar para mejorar la atención, abordando oportunidades, desafíos de adopción y claves para una integración segura y efectiva en la práctica clínica.

Moderador: Dr. Diego Benavent, Reumatólogo. Hospital Universitari de Bellvitge​. Participantes: Mar Pujadas, Co-Founder & CEO at Omniloy; Daniel Heinisch. Co-Founder & CEO at Recog Analytics

17:40h - 18:00h

Restricted access by invitation only. Acceso restringido solo con invitación

Add to calendar
 

Cierre institucional
Hall 8.0 – 4YFN & Partner Theatres

Javier Selva. DG de Transferència i Societat del Coneixement de la Generalitat de Catalunya.

18:00h

MWC Official Programme

Built-In, Not Bolt-On: Co-Designing for Inclusive Consumer Experiences
Session Speakers Marconi Stage, Hall 6

Patient Monitoring Devices @ Turing Stage

Laura Dubreuil, Director, Emerging Technology Intelligence Research

12:30h - 13:15h

Add to calendar